Skip main navigation

Conclusion and support information

Conclusion and support information

Drug discovery helps us to fight diseases and alleviate suffering.

To combat serious or new emerging disease (e.g. cancers and Ebola virus), an effective platform for drug discovery is necessary. Today, high throughput screening and structural biology are regarded as an essential part of drug discovery because both of them can reduce the developmental time of new drugs.

In this topic, you have learnt how these technologies are involved in EGFR drug design. We recommend you go back to review the first video in this week’s learning(Introduction to molecule drug discovery) again. You may have more new ideas about the drug discovery.

Supporting information

We have provided a PDF below which provides supporting information. This includes explanation of:

  1. Structural biology
  2. Yeast two-hybrid system
  3. Small compound screening
This article is from the free online

Introduction to Translational Research: Connecting Scientists and Medical Doctors

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now